Value of Core Needle Biopsy as the First Diagnostic Procedure in the Palpable Breast Masses
Authors
F Karimian1, A Aminian1,*, E Hashemi2, AP Meysamie3, R Mirsharifi4, A Alibakhshi1
1Assistant Professor, Department of General Surgery, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2General Surgeon, Iranian Center for Breast Cancer, Tehran, Iran
3Assistant Professor of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran
4Associate Professor, Department of General Surgery, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Department of General Surgery, Imam Hospital Complex, End of Keshavarz Boulevard, Tehran, Iran, aliaminian@doctor.com. Tel: +98-2166937185. Fax: +98-2166937185. Email: aliaminian@doctor.com
How to Cite:Karimian F, Aminian A, Hashemi E, Meysamie A, Mirsharifi R, et al. Value of Core Needle Biopsy as the First Diagnostic Procedure in the Palpable Breast Masses. Shiraz E-Med J. 2008;9(4):. doi:
Abstract
Background:
Breast core needle biopsy (CNB) provides enough tissue for histopathologic diagnosis and is considered a reliable method for establishing preoperative tissue diagnosis. The purpose of this study is to evaluate CNB as the first diagnostic step instead of excisional biopsy in palpable breast masses.
Materials and Methods:
In this prospective study, patients with palpable breast mass who underwent CNB were enrolled. Based on pathology report, patients with malignant lesions revealed by CNB were immediately candidate for surgery and those who had benign lesions were followed up to 3 years.
Results:
112 females with palpable breast mass were enrolled in the study. In 103 (91.9%) of cases first attempt CNB provided adequate sample tissue. CNB detected malignant lesion in seventy eight (69.6%) patients. All (100%) malignant CNB reports were confirmed at surgery specimen pathology. In 34 (30.4%) patients CNB revealed benign lesion. At the end of 3 years follow up period, 25 (73%) of these patients underwent open biopsy leading to the detection of 1 (3%) malignant tumor. Overall, according to the gold standard defined as positive surgical biopsy or positive follow-up, sensitivity of CNB was calculated as 98.7% (95% CI, 94.1-100%) and its accuracy was 99.1% (95% CI, 97.4-100%). The specificity of the CNB procedure was 100%.
Conclusion:
These findings suggest that the malignancy detection power provided by CNB may be weighed equal to that of open biopsy. Therefore, we propose CNB as the first choice in diagnostic evaluation of palpable breast mass especially for those in accessible sites and in experienced hands.
Pakdemirli E, Elkorety M, Monib S. Clinically Indeterminate Breast Lesions with Normal Imaging: A Retrospective Study in a Symptomatic Breast Care Unit. I J Radiol. 2020;17(4):e103859. doi: https://doi.org/10.5812/iranjradiol.103859
Park M, Sohn Y. Vacuum Assisted-Biopsy and Mammo-Guided Localization and Excisional Biopsy in the Microcalcifications Sampling of Breast: An Experience of Single Institution. I J Radiol. 2017;14(1):e13466. doi: https://doi.org/10.5812/iranjradiol.30535
Hashemzadeh S, Kumar P, Malekpour N, Hashemi Z, Fattahi F, et al. Diagnostic Accuracy of Fine Needle Aspiration Cytology: Comparison of Results in Tabriz Imam Khomeini Hospital and Shiraz University of Medical Sciences. Int J Cancer Manag. 2009;2(3):e80568. doi:
Sadighi N, Bahreini M, Jahanbin B, Gity M, Rahmani M, et al. Successful Stereotactic-Guided Vacuum-Assisted Biopsy in the Evaluation of Breast Microcalcifications: A Study in a Single Tertiary Referral Center in the Middle East. I J Radiol. 2022;19(2):e122269. doi: https://doi.org/10.5812/iranjradiol-122269